Rainer Scheid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rainer Scheid has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
D. Yves von Cramon
7 shared publicationsMatthias L. Schroeter
4 shared publications- Osama Sabri
Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany
3 shared publications D. Y. von Cramon
From the Day Clinic of Cognitive Neurology (R.S., D.Y.v.C.), Department of Human Genetics (W.H., S.S., U.G.F.), and Department of Neuropathology (R.S.), University of Leipzig; Max Planck Institute for Human Cognitive and Brain Sciences (R.S., D.Y.v.C.), Leipzig; Department of Psychiatry and Psychotherapy (T.L.), University of Tübingen; and Department of Neuropathology (D.R.T.), University of Ulm, Germany
2 shared publicationsM. L. Schroeter
Day Clinic of Cognitive Neurology, University of Leipzig, Leipzig
2 shared publicationsOlaf Ballaschke
2 shared publications
Latest Publications
- 9 September 2014
- Published by Georg Thieme Verlag KG in neuroreha
- Vol. 06 (03) , 117-119
Diffuser Axonschaden
Schädel-Hirn-Traumen (SHTs) sind die Folge direkter und/oder indirekter Gewalteinwirkungen auf das Gehirn. Die Neurologen teilen die Gewalteinwirkungen ein in direktes Kontaktphänomen, das Auftreten von Zug- und Druckverletzungen sowie das Einwirken von linearen und insbesondere Winkelbeschleunigungskräften auf das Gehirn, wobei diffuse/traumatische axonale Schädigungen (DAI/TAI) entstehen [10]. Der Pathomechanismus der in jüngster Zeit vermehrt Beachtung findenden „blast injuries“ ist vergleichsweise wenig bekannt. Derartige Verletzungen zeichnen sich insbesondere durch das Auftreten subarachnoidaler Blutungen und Vasospasmen sowie eine frühe und schwere Ödemkomponente aus [19]. Der folgende Beitrag wirft einen Fokus auf den Komplex der diffusen und traumatischen axonalen Schädigung.
- 9 September 2014
- Published by Georg Thieme Verlag KG in neuroreha
- Vol. 06 (03) , 117-119
Diffuser Axonschaden
Schädel-Hirn-Traumen (SHTs) sind die Folge direkter und/oder indirekter Gewalteinwirkungen auf das Gehirn. Die Neurologen teilen die Gewalteinwirkungen ein in direktes Kontaktphänomen, das Auftreten von Zug- und Druckverletzungen sowie das Einwirken von linearen und insbesondere Winkelbeschleunigungskräften auf das Gehirn, wobei diffuse/traumatische axonale Schädigungen (DAI/TAI) entstehen [10]. Der Pathomechanismus der in jüngster Zeit vermehrt Beachtung findenden „blast injuries“ ist vergleichsweise wenig bekannt. Derartige Verletzungen zeichnen sich insbesondere durch das Auftreten subarachnoidaler Blutungen und Vasospasmen sowie eine frühe und schwere Ödemkomponente aus [19]. Der folgende Beitrag wirft einen Fokus auf den Komplex der diffusen und traumatischen axonalen Schädigung.
- 26 March 2010
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 107 (12) , 199-205
Clinical Findings in the Chronic Phase of Traumatic Brain Injury
Traumatic brain injury (TBI) is one of the commonest disorders within neuropsychiatry in its widest sense. The incidence of TBI in Germany is approximately 332 per 100 000, in comparison to 182 per 100 000 for strokes (1, 2). Its annual direct and...
- 26 March 2010
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 107 (12) , 199-205
Clinical Findings in the Chronic Phase of Traumatic Brain Injury
Traumatic brain injury (TBI) is one of the commonest disorders within neuropsychiatry in its widest sense. The incidence of TBI in Germany is approximately 332 per 100 000, in comparison to 182 per 100 000 for strokes (1, 2). Its annual direct and...
- 27 October 2009
- Published by Wolters Kluwer Health in Neurology
- Vol. 73 (17) , 1419-1422
DEVELOPMENT OF MESIAL TEMPORAL LOBE EPILEPSY IN CHOREA-ACANTHOCYTOSIS
- 27 October 2009
- Published by Wolters Kluwer Health in Neurology
- Vol. 73 (17) , 1419-1422
DEVELOPMENT OF MESIAL TEMPORAL LOBE EPILEPSY IN CHOREA-ACANTHOCYTOSIS
- 7 September 2009
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 34 (5) , 603-605
Superficial siderosis of the central nervous system - treatment with steroids?
Steroids have been suggested as a therapeutic option for superficial siderosis of the central nervous system (SSCNS) without identifiable bleeding source. Longitudinal observational data of a patient with idiopathic SSCNS who was repeatedly treated with methylprednisolone over a course of 2 years are reported. The case history is critically discussed on the background of the sparse literature. In conclusion, if at all, there is only a limited and temporary, mostly subjective clinical response to steroids in SSCNS. Systematic studies of this medication in SSCNS do not seem warranted. Pathophysiological considerations hopefully may lead to more helpful medications for this chronic and debilitating disorder.
- 7 September 2009
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 34 (5) , 603-605
Superficial siderosis of the central nervous system - treatment with steroids?
Steroids have been suggested as a therapeutic option for superficial siderosis of the central nervous system (SSCNS) without identifiable bleeding source. Longitudinal observational data of a patient with idiopathic SSCNS who was repeatedly treated with methylprednisolone over a course of 2 years are reported. The case history is critically discussed on the background of the sparse literature. In conclusion, if at all, there is only a limited and temporary, mostly subjective clinical response to steroids in SSCNS. Systematic studies of this medication in SSCNS do not seem warranted. Pathophysiological considerations hopefully may lead to more helpful medications for this chronic and debilitating disorder.
- Open Access
- 13 December 2008
- Published by Springer Nature in Neuroradiology
- Vol. 51 (2) , 131-133
Now you see it, now you don’t—the hidden life of cerebral dural arteriovenous fistulae
- 13 December 2008
- Published by Springer Nature in Neuroradiology
- Vol. 51 (2) , 131-133
Open AccessNow you see it, now you don’t—the hidden life of cerebral dural arteriovenous fistulae
- 1 December 2008
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 110 (10) , 1054-1057
Cognitive dysfunction, urinary retention, and a lesion in the thalamus—Beware of possible toxocariasis of the central nervous system
- 1 December 2008
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 110 (10) , 1054-1057
Cognitive dysfunction, urinary retention, and a lesion in the thalamus—Beware of possible toxocariasis of the central nervous system
- 2 September 2008
- Published by Wolters Kluwer Health in Neurology
- Vol. 71 (10) , 774-776
CYSTEINE-SPARING NOTCH3 MUTATIONS: CADASIL OR CADASIL VARIANTS?
Mutations in the Notch3 gene in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) usually involve cysteine residues.1 We report a cysteine-sparing mutation (A1020P) in association with a CADASIL-compatible phenotype in two German families. ### Case histories. The index patient 1 is a 49-year-old woman with a medical history of sensorineural hearing loss of adolescent onset. At the age of 34, arterial hypertension was diagnosed. Since her 40s she reported episodes of unilateral headache, vertigo, and nausea. In addition, the patient had intermittent paresthesias and weakness of the left extremities, reduced fine motor skills, cognitive slowing, and impaired memory. MRI in 2003 revealed widespread T2-hyperintense white matter lesions (WMLs) (figure, A). Electron microscopic examination of a skin biopsy showed deposits of osmiophilic material between the smooth-muscle cells of small arteries (figure e-1 on the Neurology ® Web site at www.neurology.org), and immunostaining with a Notch3 monoclonal antibody showed granular labeling of vascular smooth-muscle cells (figure e-2). Figure Axial T2-weighted (A, C, E) and fluid-attenuated inversion recovery MRIs (B, D) of the index patient (A), the index patient’s mother (B), and patient 2 (D), compatible with widespread ischemic leukoaraiosis Note especially the absence of white matter lesions (WMLs) in the anterior temporal lobes in all three individuals. The MRI of the index patient’s uncle (C), although characterized as a mutation carrier, only showed a slight pallor of the white matter and dilated Virchow Robin spaces. (E) MRI of the father of the …
- 2 September 2008
- Published by Wolters Kluwer Health in Neurology
- Vol. 71 (10) , 774-776
CYSTEINE-SPARING NOTCH3 MUTATIONS: CADASIL OR CADASIL VARIANTS?
Mutations in the Notch3 gene in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) usually involve cysteine residues.1 We report a cysteine-sparing mutation (A1020P) in association with a CADASIL-compatible phenotype in two German families. ### Case histories. The index patient 1 is a 49-year-old woman with a medical history of sensorineural hearing loss of adolescent onset. At the age of 34, arterial hypertension was diagnosed. Since her 40s she reported episodes of unilateral headache, vertigo, and nausea. In addition, the patient had intermittent paresthesias and weakness of the left extremities, reduced fine motor skills, cognitive slowing, and impaired memory. MRI in 2003 revealed widespread T2-hyperintense white matter lesions (WMLs) (figure, A). Electron microscopic examination of a skin biopsy showed deposits of osmiophilic material between the smooth-muscle cells of small arteries (figure e-1 on the Neurology ® Web site at www.neurology.org), and immunostaining with a Notch3 monoclonal antibody showed granular labeling of vascular smooth-muscle cells (figure e-2). Figure Axial T2-weighted (A, C, E) and fluid-attenuated inversion recovery MRIs (B, D) of the index patient (A), the index patient’s mother (B), and patient 2 (D), compatible with widespread ischemic leukoaraiosis Note especially the absence of white matter lesions (WMLs) in the anterior temporal lobes in all three individuals. The MRI of the index patient’s uncle (C), although characterized as a mutation carrier, only showed a slight pallor of the white matter and dilated Virchow Robin spaces. (E) MRI of the father of the …
- 1 March 2008
- Published by Wolters Kluwer Health in Cognitive and Behavioral Neurology
- Vol. 21 (1) , 52-54
Aerophagia and Belching After Herpes Simplex Encephalitis
The etiology of abnormal belching is not known. Currently, it is being subsumed under "functional gastroduodenal disorders." Here, we report the unusual case history of a patient who developed aerophagia and consecutive excessive belching in association with herpes simplex encephalitis. The case report adds to the limited information about potential organic geneses of belching. Implications for possible medical therapies are discussed.
- 1 March 2008
- Published by Wolters Kluwer Health in Cognitive and Behavioral Neurology
- Vol. 21 (1) , 52-54
Aerophagia and Belching After Herpes Simplex Encephalitis
The etiology of abnormal belching is not known. Currently, it is being subsumed under "functional gastroduodenal disorders." Here, we report the unusual case history of a patient who developed aerophagia and consecutive excessive belching in association with herpes simplex encephalitis. The case report adds to the limited information about potential organic geneses of belching. Implications for possible medical therapies are discussed.
- 1 December 2007
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 24 (12) , 1811-1816
Comparative Magnetic Resonance Imaging at 1.5 and 3 Tesla for the Evaluation of Traumatic Microbleeds
Traumatic microbleeds (TMBs) can be regarded as a radiological marker of diffuse axonal injury (DAI). We sought to investigate the impact of the field strengths on the depiction of TMBs by T2*-weighted gradient echo magnetic resonance imaging (MRI). By the use of comparative MRI of 14 patients (age range, 22–62 years) on 1.5- and a 3 T (Tesla) systems at a median time interval of 61 months after traumatic brain injury (TBI), we found 239 (range 0.5–48.5, median 7.5) TMBs at 1.5 T, and 470 (range 2–118, median 18.5) TMBs at 3 T, respectively (p = 0.001). However, in all but one patients MRI at 1.5 T also clearly showed TMBs. A significant negative correlation between the number of TMBs and the time interval TBI–MRI was observed, which was weaker for the imaging at 3 T (rs = 0.798; p = 0.001; and rs = 0.649; p = 0.012, respectively). In conclusion, T2*-weighted gradient-echo MRI at 3 T is superior as compared to MRI at 1.5 T for the detection of TMBs. Nevertheless, in clinical practice, MRI at 1.5 T seems to be sufficient for this purpose. MRI at 3 T may be appropriate if there is a strong clinical suspicion of DAI, despite unremarkable routine MRI, and possibly also if evidence of DAI is sought after a long interval from trauma.
- 1 December 2007
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 24 (12) , 1811-1816
Comparative Magnetic Resonance Imaging at 1.5 and 3 Tesla for the Evaluation of Traumatic Microbleeds
Traumatic microbleeds (TMBs) can be regarded as a radiological marker of diffuse axonal injury (DAI). We sought to investigate the impact of the field strengths on the depiction of TMBs by T2*-weighted gradient echo magnetic resonance imaging (MRI). By the use of comparative MRI of 14 patients (age range, 22–62 years) on 1.5- and a 3 T (Tesla) systems at a median time interval of 61 months after traumatic brain injury (TBI), we found 239 (range 0.5–48.5, median 7.5) TMBs at 1.5 T, and 470 (range 2–118, median 18.5) TMBs at 3 T, respectively (p = 0.001). However, in all but one patients MRI at 1.5 T also clearly showed TMBs. A significant negative correlation between the number of TMBs and the time interval TBI–MRI was observed, which was weaker for the imaging at 3 T (rs = 0.798; p = 0.001; and rs = 0.649; p = 0.012, respectively). In conclusion, T2*-weighted gradient-echo MRI at 3 T is superior as compared to MRI at 1.5 T for the detection of TMBs. Nevertheless, in clinical practice, MRI at 1.5 T seems to be sufficient for this purpose. MRI at 3 T may be appropriate if there is a strong clinical suspicion of DAI, despite unremarkable routine MRI, and possibly also if evidence of DAI is sought after a long interval from trauma.
- 11 April 2007
- Published by Wiley in European Journal of Neurology
- Vol. 14 (5) , 483-493
Neurologic manifestations of ulcerative colitis
Ulcerative colitis (UC) has traditionally been considered to be an inflammatory disease limited to the colonic mucosa. However, since it has been shown that UC is frequently accompanied by various extraintestinal disorders, there is increasing evidence that UC may also manifest in the nervous system. The following review focuses particularly on these possible manifestations of UC, both in the peripheral (PNS), and in the central nervous system (CNS). A systematic literature search according to the MEDLINE database was performed for this purpose. Although a reliable differentiation may clinically not always be possible, three major pathogenic entities can be differentiated: (i) cerebrovascular disease as a consequence of thrombosis and thromboembolism; (ii) systemic and cerebral vasculitis; (iii) probably immune mediated neuropathy and cerebral demyelination. With the exception of thromboembolism and sensorineural hearing loss, evidence for a causal relationship relies merely on single case reports or retrospective case series. Considering the CNS‐manifestations, similarities between UC‐associated disorders of the white matter and acute disseminated encephalomyelitis (ADEM) are obvious. Epileptic seizures, unspecified encephalopathies and confusional states are most likely epiphenomena that have to be regarded symptomatic rather than as own entities. A prospective study on the neurologic aspects of UC would be very welcome.
- 11 April 2007
- Published by Wiley in European Journal of Neurology
- Vol. 14 (5) , 483-493
Neurologic manifestations of ulcerative colitis
Ulcerative colitis (UC) has traditionally been considered to be an inflammatory disease limited to the colonic mucosa. However, since it has been shown that UC is frequently accompanied by various extraintestinal disorders, there is increasing evidence that UC may also manifest in the nervous system. The following review focuses particularly on these possible manifestations of UC, both in the peripheral (PNS), and in the central nervous system (CNS). A systematic literature search according to the MEDLINE database was performed for this purpose. Although a reliable differentiation may clinically not always be possible, three major pathogenic entities can be differentiated: (i) cerebrovascular disease as a consequence of thrombosis and thromboembolism; (ii) systemic and cerebral vasculitis; (iii) probably immune mediated neuropathy and cerebral demyelination. With the exception of thromboembolism and sensorineural hearing loss, evidence for a causal relationship relies merely on single case reports or retrospective case series. Considering the CNS‐manifestations, similarities between UC‐associated disorders of the white matter and acute disseminated encephalomyelitis (ADEM) are obvious. Epileptic seizures, unspecified encephalopathies and confusional states are most likely epiphenomena that have to be regarded symptomatic rather than as own entities. A prospective study on the neurologic aspects of UC would be very welcome.